U.S. Pharma Stock News

Wondering if SharpLink Gaming at around $9.81 is a hidden value opportunity or a value trap? You are not alone; this stock has started to pop up on more radars lately. Over the last week the share price is up 3.2%, roughly matching its 3.0% gain over the past month, but the real eye catcher is the 21.4% return year to date after a tough 3 year slide of 74.1%. Recent headlines have focused on SharpLink Gaming's strategic push deeper into sports betting technology and partnerships with media...

If you are wondering whether DraftKings at around $34 a share is a bargain or a bubble, you are not alone. This article walks through what the numbers really say about its value. Over the last month the stock is up 14.1%, but that comes after a choppy run, with the shares down 3.9% over the past week, 5.7% year to date, and 10.8% over the last year. The 3 year return still sits at an eye catching 196.7%. Those swings have been underpinned by ongoing state by state legalization and expansion...

Earlier this month, ExlService Holdings completed a US$63.37 million repurchase of 1,551,970 shares at US$40.83 each from Orogen Echo LLC, alongside reporting a quarter of 12% revenue growth and 11% adjusted EPS growth powered by its data and AI offerings. At the same time, EXL’s full migration of its LifePRO Digital Suite to Amazon Web Services highlights how its AI-enabled, cloud-based platforms are reshaping life and annuity operations for global insurers. Next, we’ll explore how EXL’s...

B. Riley Securities just kicked off coverage on PROG Holdings, giving the stock a fresh spotlight and a clearly positive stance that could reshape how investors think about this underfollowed lender. See our latest analysis for PROG Holdings. That fresh coverage lands after a choppy stretch, with a recent 1 month share price return of 6.55 percent but a much weaker year to date share price return of minus 29.20 percent. Even so, the 3 year total shareholder return of 79.37 percent still...

With a price-to-earnings (or "P/E") ratio of 30.9x US Foods Holding Corp. ( NYSE:USFD ) may be sending very bearish...

KeyBanc just kicked off coverage on LivaNova (LIVN) with an Overweight call, highlighting what it sees as underappreciated growth from capital equipment cycles, share gains, better clinical data, and upcoming aura6000 commercialization. See our latest analysis for LivaNova. The upbeat initiation comes as LivaNova’s share price has climbed 34.66 percent year to date and delivered a 33.69 percent total shareholder return over the past year. This suggests momentum is building as investors...

Taysha Gene Therapies recently received FDA Breakthrough Therapy Designation for its Rett syndrome gene therapy candidate TSHA-102 and secured regulatory alignment on the pivotal REVEAL trial protocol, including a planned six-month interim analysis to support a future Biologics License Application. This combination of regulatory recognition and a clearly defined clinical pathway adds important validation to TSHA-102’s potential and clarifies how quickly the Rett program could progress toward...

Post Holdings (POST) has given investors plenty to chew on lately, with fresh $1.3 billion senior notes, stronger than expected quarterly numbers, and a new $500 million buyback reshaping its capital playbook. See our latest analysis for Post Holdings. At around $100.83 per share, Post’s 1 month share price return has been modestly positive but its year to date share price return is still clearly negative. A 5 year total shareholder return in the mid 40 percent range shows the longer term...

The Morning Bull - US Market Morning Update Monday, Dec, 22 2025 US stock futures are pointing higher this morning, with E mini S&P 500 contracts up about 0.3 percent as investors juggle stronger housing data and stubborn inflation expectations. Existing home sales ticked up 0.5 percent in November to a nine month high, a sign that higher mortgage rates are not fully freezing the housing market. This matters for construction jobs and household wealth. At the same time, a key consumer...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

GlobalFoundries recently appointed Sam Franklin as Chief Financial Officer, cementing leadership continuity as he moves from Interim CFO into the permanent role with broad responsibility for finance and operations. At the same time, GlobalFoundries is exiting the Nasdaq-100 while securing nearly €495 million in German government aid to expand its Dresden semiconductor facilities and deepen its position in power semiconductors and silicon photonics for AI data centers. Next, we’ll explore how...

Cantor Fitzgerald recently reiterated its Overweight rating on Summit Therapeutics while Barclays upgraded the stock to Equalweight, spotlighting ivonescimab’s planned late-2025 Biologics License Application submission and the pivotal global phase 3 HARMONi-3 lung cancer study expected in 2026. These endorsements underscore how ivonescimab and the HARMONi-3 program have moved to the center of the biotech conversation around late-stage oncology assets. With Summit Therapeutics’ shares...

We wouldn't blame ATI Inc. ( NYSE:ATI ) shareholders if they were a little worried about the fact that Robert...

It is hard to get excited after looking at Comstock Holding Companies' (NASDAQ:CHCI) recent performance, when its stock...

First Financial Corporation ( NASDAQ:THFF ) will increase its dividend on the 15th of January to $0.56, which is 9.8...

Washington Trust Bancorp, Inc. ( NASDAQ:WASH ) has announced that it will pay a dividend of $0.56 per share on the 14th...

Over the past year, many Snap-on Incorporated ( NYSE:SNA ) insiders sold a significant stake in the company which may...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...

Wondering if Johnson & Johnson is still a buy at around $206 a share, or if the easy gains are already behind it? This breakdown will help you decide whether the current price matches the company’s long term fundamentals. Despite a recent dip of 3.6% over the last week, the stock is still up 1.2% over the past month, 43.3% year to date and 46.4% over the last year, which indicates the market has been steadily re-rating J&J’s prospects. That momentum has been shaped by a stream of news, from...

Earlier this week, Coastal Financial, a banking services provider focused on community banking, saw renewed investor interest as robust earnings growth forecasts drew fresh attention from institutional investors. This reaction highlights how confidence from large investors can reinforce market belief in Coastal Financial’s community banking business model and earnings potential. We’ll now examine how this renewed institutional confidence shapes Coastal Financial’s investment narrative and...

Earlier this month, KeyBanc Capital Markets initiated coverage of Kratos Defense & Security Solutions with an Overweight rating, emphasizing its exposure to hypersonics, collaborative combat aircraft drones, and other advanced Pentagon programs alongside recent facility expansions in Vancouver, Jerusalem, and Michigan. This combination of bullish analyst coverage and growing production footprint highlights how Kratos is increasingly aligned with modernization priorities in global defense...

Piper Sandler just kicked off coverage of First Commonwealth Financial (FCF) with an Overweight rating, spotlighting its stronger than peer returns, accelerating earnings, and a valuation that still sits at a discount. See our latest analysis for First Commonwealth Financial. At a share price of $17.26, First Commonwealth’s 1 month share price return of 7.14% contrasts with a softer 90 day share price return, while a 5 year total shareholder return of 87.46% points to durable, if currently...

Photronics (PLAB) has quietly turned into one of those under the radar chip enablers powering the broader semiconductor cycle, and its recent share performance now has investors asking whether the run still has room. See our latest analysis for Photronics. With the share price now at $33.09, Photronics has cooled off a bit after a sharp run, but a 57.12 percent one month share price return and 38.74 percent one year total shareholder return still point to momentum that investors clearly have...

Morgan Stanley recently upgraded Warner Music Group to overweight while several insiders bought shares, coinciding with broad analyst optimism about the company’s prospects. At the same time, Warner Music Group has been cutting costs through layoffs and restructuring, highlighting management’s push to boost efficiency alongside growth initiatives. We’ll now examine how insider share purchases, alongside these restructuring efforts, may influence Warner Music Group’s broader investment...